@article{TCR11312,
author = {Hao Zheng and Aswini R. Krishnan and Angela E. Zou and Weg M. Ongkeko},
title = {The role of long noncoding RNA FOXF1-AS1 as a tumor suppressor in non-small cell lung cancer},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 7},
year = {2016},
keywords = {},
abstract = {Non-small cell lung cancer (NSCLC) accounts for approximately 80% of lung cancer cases and is the leading cause of cancer-related death in the United States (1). A significant challenge associated with NSCLC treatment is the lack of early diagnostic tools, as more than 70% of NSCLC patients are diagnosed at advanced stages, rendering them ineligible for surgical resection (2). Advanced-stage NSCLCs are generally treated by platinum-based chemotherapy or radiation therapy, but both treatments are highly invasive with low specificity and high recurrence rate (3-5).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/11312}
}